About Thoratec
Thoratec is a Healthcare company based in Pleasanton (United States) founded in 1979. Proprietary medical devices for circulatory support are developed and marketed. The company has 215 employees. Thoratec has completed 1 acquisition, including Apica Cardiovascular. The company has since been acquired. Thoratec offers products and services including Assert-IQâ„¢ Insertable Cardiac Monitor, AVEIRâ„¢ DR Dual Chamber Leadless Pacemaker, and CardioMEMSâ„¢ HF System. Its focus areas include Life Sciences, Cardiac and Vascular Disorders, Medical Devices and Therapeutic Devices. Its legal entity is THORATEC CORPORATION. Its competitors include CVRx, Adona Medical and Element Science; 3 of its 3 listed competitors have raised funding.
Company details
Thoratec Corporation develops, manufactures, and markets proprietary medical devices used for mechanical circulatory support. Mechanical support for blood circulation is often required in heart failure patients. Thoratecs main lines include ventricular assist devices such as HeartMate II, an implantable, electrically powered, continuous flow, left ventricular assist device (LVAD) that consists of a rotary pump designed to provide long-term mechanical circulatory support (MCS).Its portfolio also includes ventricular assist devices for children and products for bridge-to-transplantation (BTT) and post-cardiotomy myocardial recovery. In 2014 Thortec acquired Apica cardiovascular for 75M.
- Headquarters Pleasanton, United States
- Employees 215
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website thoratec.com
- Social LinkedIn X Facebook
- Legal Name Thoratec Corporation
- Latest Funding Round$2.75M (USD), Grant
Sep 2009
- Investors
- Employee Count215
- Investments & Acquisitions
Products & Services of Thoratec
Thoratec offers a comprehensive portfolio of products and services, including Assert-IQ™ Insertable Cardiac Monitor, AVEIR™ DR Dual Chamber Leadless Pacemaker, and CardioMEMS™ HF System.
Inserts to monitor heart rhythms and detect abnormalities.
Delivers pacing for abnormal heart rhythms without leads.
Monitors pulmonary artery pressures in heart failure patients.
Funding Insights of Thoratec
- Total Rounds 1
- Last Round Grant — $2.75M
- First Round $2.75M
(Sep 2009)
- Investors Count 1
All 1 funding rounds of Thoratec with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2009 | $2.75M | Grant | – | – |
1 investors in total: 1 institutional.
Investors in Thoratec
Thoratec has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov |
Investor details for Thoratec
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Thoratec
1328 people are tracked at Thoratec (535 in leadership, 13 in board & advisors, 780 in team); the tracked headcount is 215.
| Name | Role | Group |
|---|---|---|
Esther Chagoya | Director Strategic Initiatives And Communications | Leadership |
Juan Manuel Fonseca Saravia | General Manager | Leadership |
Charles Craig | Director Cybersecurity Services | Leadership |
Trevor Burlison | Area Vice President | Leadership |
Diana Luo | Divisional Vice President, Commercial Legal, Structural Heart And Heart Failure | Leadership |
Eric Ryan | Director, Adult Global Marketing | Leadership |
Hoai Trinh | Regional HR Director | Leadership |
Lauren White | Director Of Cybersecurity | Leadership |
Christian Moormann | Head of Product Development | Leadership |
Meghan Griffin | Global Clinical Program Director | Leadership |
Alexa Bisinger | Area Medical Director - Americas | Leadership |
Vahe Ayvazian | Divisional Vice President Global Diagnostics | Leadership |
Karen Rodriguez | Division Vice President Operations, Rapid Diagnostics | Leadership |
Ding | Chief Cybersecurity Architect | Leadership |
Vildan Kehr | Divisional Vice President, Human Resources, Rapid And Molecular Diagnostics | Leadership |
Ramon Neira | Division VP and Controller, Emerging Markets, Infectious Diseases, Rapid Diagnostics | Leadership |
Darshan Gada | Regional Finance Director - Abbott India | Leadership |
Dr. Ursula Christian | R&d Divisional Vice President Product Development, Hematology | Leadership |
Linda Wang | General Manager, Dvp, Epd, Abbott China | Leadership |
Charmaine Goh | HR Business Partner (on Contract) | Leadership |
1308 more people are available in the full profile.
Complete people profiles for Thoratec
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Thoratec
Thoratec has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Apica Cardiovascular.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Transapical surgical access devices for heart procedures are developed. | apica.ie | Galway, Ireland | 2009 | Jul 2014 | $35M |
Complete acquisition details for Thoratec
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Thoratec
4 dated milestones of Thoratec across 35 years, from founding to its latest funding, stage changes and deals.
- Founded Thoratec is founded.
- IPO Lists on the stock exchange (IPO).
- Funding First funding round of $2.8M.
- Acquisition Acquires Apica Cardiovascular.
Competitors of Thoratec
Thoratec has 3 listed competitors in our database, 3 of them funded. They include CVRx, Adona Medical and Element Science.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| cvrx.com | 2001 | Minneapolis, United States | $368.5M | 142 | Implantable technology for hypertension and heart failure is developed. | |
| adonamed.com | 2017 | Campbell, United States | $71M | Medical devices for heart failure management are developed. | ||
| elementscience.com | 2013 | San Francisco, United States | $192.6M | Wearable patch defibrillators are developed for sudden cardiac arrest treatment. |
Detailed competitors of Thoratec
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Thoratec
Websites that share an audience with Thoratec (thoratec.com).
Websites whose visitors overlap most with Thoratec. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| heartware.com | 100% | View details | |||
| medtronic.com | 100% | 2.6M | #22,622 | View details | |
| abiomed.com | 99% | 34.6K | #890,751 | View details | |
| bostonscientific.com | 96% | 738.5K | #88,615 | View details | |
| sjm.com | 83% | 1.2K | #13,629,967 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 27 similar websites and full traffic analytics for Thoratec
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 27 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Cardiac and Vascular Disorders
3 companies that operate in the same segment as Thoratec (Cardiac and Vascular Disorders) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Gene-editing therapies for coronary artery disease are developed. | 2018 | Cambridge, Massachusetts, United States | USD 215.5 M | 255 | ||
Cardiac monitoring devices and applications are provided for heart health. | 2010 | Mountain View, California, United States | USD 114.38 M | USD 6.18 M | 67 | |
Therapies for lowering low-density lipoprotein cholesterol levels are developed. | 1998 | Ann Arbor, Michigan, United States | USD 129.7 M | USD 332.31 M | 304 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Thoratec
Complete news archive for Thoratec
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Thoratec
Thoratec was founded in 1979 and raised its 1st funding round 30 years after it was founded.
Thoratec is headquartered in Pleasanton, United States. It is registered at Pleasanton, California, United States.
Thoratec has 215 employees.
Thoratec Corporation develops, manufactures, and markets proprietary medical devices used for mechanical circulatory support. Mechanical support for blood circulation is often required in heart failure patients. Thoratecs main lines include ventricular assist devices such as HeartMate II, an implantable, electrically powered, continuous flow, left ventricular assist device (LVAD) that consists of a rotary pump designed to provide long-term mechanical circulatory support (MCS).Its portfolio also includes ventricular assist devices for children and products for bridge-to-transplantation (BTT) and post-cardiotomy myocardial recovery. In 2014 Thortec acquired Apica cardiovascular for 75M.
Thoratec's top competitors include CVRx, Adona Medical and Element Science.
Thoratec offers Assert-IQâ„¢ Insertable Cardiac Monitor, AVEIRâ„¢ DR Dual Chamber Leadless Pacemaker, and CardioMEMSâ„¢ HF System.
Thoratec has made 1 acquisition, including Apica Cardiovascular.
Thoratec has 1 investor. Key investors include HHS.
Thoratec operates through Thoratec Corporation.